Select Medical (SEM) to Release Earnings on Thursday

Select Medical (NYSE:SEM) is expected to be posting its Q1 2026 results after the market closes on Thursday, April 30th. Analysts expect Select Medical to post earnings of $0.43 per share and revenue of $1.4110 billion for the quarter. Select Medical has set its FY 2026 guidance at 1.220-1.320 EPS. Individuals are encouraged to explore the company’s upcoming Q1 2026 earning overview page for the latest details on the call scheduled for Friday, May 1, 2026 at 9:00 AM ET.

Select Medical (NYSE:SEM) last issued its earnings results on Thursday, February 19th. The health services provider reported $0.16 EPS for the quarter, missing the consensus estimate of $0.23 by ($0.07). Select Medical had a return on equity of 7.26% and a net margin of 2.68%.The business had revenue of $1.40 billion for the quarter, compared to the consensus estimate of $1.36 billion. During the same quarter in the prior year, the firm posted $0.18 earnings per share. The business’s revenue was up 6.4% compared to the same quarter last year. On average, analysts expect Select Medical to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Select Medical Stock Performance

Shares of NYSE SEM traded up $0.05 during midday trading on Tuesday, hitting $16.50. 612,370 shares of the company’s stock were exchanged, compared to its average volume of 1,755,368. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.89. Select Medical has a 12 month low of $11.65 and a 12 month high of $18.60. The company’s 50 day moving average price is $16.12 and its 200 day moving average price is $15.18. The firm has a market capitalization of $2.05 billion, a PE ratio of 14.34, a price-to-earnings-growth ratio of 0.94 and a beta of 1.12.

Select Medical Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, March 12th. Stockholders of record on Monday, March 2nd were paid a dividend of $0.0625 per share. This represents a $0.25 annualized dividend and a dividend yield of 1.5%. The ex-dividend date was Monday, March 2nd. Select Medical’s payout ratio is currently 21.74%.

Select Medical announced that its board has initiated a stock buyback plan on Thursday, February 19th that permits the company to repurchase $1.00 billion in shares. This repurchase authorization permits the health services provider to purchase up to 49.5% of its stock through open market purchases. Stock repurchase plans are often a sign that the company’s board of directors believes its stock is undervalued.

Institutional Trading of Select Medical

A number of institutional investors have recently modified their holdings of SEM. Smartleaf Asset Management LLC increased its holdings in Select Medical by 37.8% in the 4th quarter. Smartleaf Asset Management LLC now owns 2,870 shares of the health services provider’s stock worth $43,000 after purchasing an additional 788 shares in the last quarter. Wilmington Savings Fund Society FSB increased its holdings in Select Medical by 20.9% in the 3rd quarter. Wilmington Savings Fund Society FSB now owns 5,784 shares of the health services provider’s stock worth $74,000 after purchasing an additional 999 shares in the last quarter. California State Teachers Retirement System increased its holdings in Select Medical by 1.4% in the 2nd quarter. California State Teachers Retirement System now owns 102,230 shares of the health services provider’s stock worth $1,552,000 after purchasing an additional 1,418 shares in the last quarter. Quarry LP acquired a new position in Select Medical in the 4th quarter worth about $26,000. Finally, Caitong International Asset Management Co. Ltd acquired a new position in Select Medical in the 4th quarter worth about $28,000. 89.48% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on the company. Royal Bank Of Canada restated a “sector perform” rating and issued a $16.50 price target (down from $19.00) on shares of Select Medical in a research note on Tuesday, March 3rd. Weiss Ratings upgraded Select Medical from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, February 20th. Zacks Research downgraded Select Medical from a “hold” rating to a “strong sell” rating in a research note on Thursday, February 26th. Benchmark downgraded Select Medical from a “buy” rating to a “hold” rating in a research note on Wednesday, March 4th. Finally, Wall Street Zen downgraded Select Medical from a “buy” rating to a “hold” rating in a research note on Monday, March 9th. One investment analyst has rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, Select Medical has a consensus rating of “Hold” and a consensus price target of $15.63.

About Select Medical

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.